Optimal Duration of Hydrodistension for Symptomatic Treatment of Interstitial Cystitis: A Systematic Review
HD remains a contentious treatment option for IC, with limited long-term results in the literature. Our study suggests longer HD times may result in improved efficacy and duration of symptom relief but in the setting of potentially increased risks of severe complications including bladder perforation. Risk of bias, observational study designs, heterogeneity, and lack direct comparisons in durations of HD limits our conclusions. This review underscores the need for larger, prospective trials determining the effects of HD duration on treatment efficacy.
Authors
- Scott Donnellan
- Zein Alhamdani (ORCID: https://orcid.org/0000-0002-9222-6781)
- Kirby R. Qin (ORCID: https://orcid.org/0000-0001-5215-5985)
- Paul Manohar (ORCID: https://orcid.org/0000-0001-7429-4687)
- Matthew Harper (ORCID: https://orcid.org/0000-0002-0102-4616)
- Sean Lim (ORCID: https://orcid.org/0000-0002-5921-9643)
- Weranja Ranasinghe (ORCID: https://orcid.org/0000-0002-4006-0388)
- Alexander L. Nesbitt (ORCID: https://orcid.org/0000-0003-0741-5383)
- Janelle Brennan (ORCID: https://orcid.org/0000-0002-0470-2734)
Institutions
- Monash Health (AU)
- Bendigo Health (AU)
- Austin Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Neurourology and Urodynamics
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1002/nau.70190
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00